Brief: Burning Rock Biotech Q3 Loss Per Class A & Class B Share RMB 1.64

Burning Rock Biotech

16/11/2021 02:12

Nov 15 (Reuters) - Burning Rock Biotech Ltd  BNR.O :
    * Q3 LOSS PER CLASS A & CLASS B SHARE - RMB 1.64
    * BURNING ROCK REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS
    * Q3 REVENUE ROSE 2.2 PERCENT TO RMB 126.6 MILLION
    * BURNING ROCK BIOTECH - EXPECT OUR CENTRAL-LABORATORY
TESTING
VOLUMES AND GROWTH OF OUR IN-HOSPITAL TESTING VOLUMES, TO BE
SIGNIFICANTLY IMPACTED
    * BURNING ROCK BIOTECH - EXPECT OUR 2021 FY REVENUE TO BE AT
OR
AROUND RMB500 MILLION, SUBJECT TO FUTURE DEVELOPMENT OF CURRENT
WAVE OF COVID RESURGENCE

Source text for Eikon:  ID:nGNX7MNWqh 
Further company coverage:  BNR.O 

 ((Reuters.Briefs@thomsonreuters.com;))